Mercer Global Advisors Inc Eli Lilly & CO Transaction History

Mercer Global Advisors Inc

$45.6 Billion
Q3 2024

A detailed history of Mercer Global Advisors Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Mercer Global Advisors Inc holds 702,834 shares of LLY stock, worth $530 Million. This represents 1.36% of its overall portfolio holdings.

Number of Shares

702,834

Previous 694,060 1.26%

Holding current value

$530 Million

Previous $628 Million 0.91%

% of portfolio

1.36%

Previous 1.59%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$772.14 - $960.02 $6.77 Million - $8.42 Million	8,774 Added 1.26%	702,834 $623 Million
Q2 2024 Aug 12, 2024	BUY	$724.87 - $909.04 $1.94 Million - $2.44 Million	2,681 Added 0.39%	694,060 $628 Million
Q1 2024 May 15, 2024	SELL	$592.2 - $792.28 $4.8 Million - $6.42 Million	-8,109 Reduced 1.16%	691,379 $538 Million
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $314 Million - $370 Million	597,436 Added 585.42%	699,488 $408 Million
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $1.52 Million - $2.1 Million	-3,498 Reduced 3.31%	102,052 $54.8 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $6.11 Million - $8.18 Million	17,434 Added 19.79%	105,550 $49.5 Million
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $656,050 - $770,499	2,112 Added 2.46%	88,116 $30.3 Million
Q4 2022 Feb 08, 2023	BUY	$321.55 - $374.67 $2.76 Million - $3.21 Million	8,573 Added 11.07%	86,004 $31.5 Million
Q3 2022 Nov 15, 2022	BUY	$296.48 - $337.87 $250,822 - $285,838	846 Added 1.1%	77,431 $25 Million
Q2 2022 Aug 10, 2022	BUY	$278.73 - $327.27 $1.95 Million - $2.28 Million	6,980 Added 10.03%	76,585 $24.8 Million
Q1 2022 May 10, 2022	BUY	$234.69 - $291.66 $1.81 Million - $2.25 Million	7,716 Added 12.47%	69,605 $19.9 Million
Q4 2021 Feb 04, 2022	BUY	$224.85 - $279.04 $190,447 - $236,346	847 Added 1.39%	61,889 $17.1 Million
Q3 2021 Nov 10, 2021	SELL	$221.6 - $272.71 $522,089 - $642,504	-2,356 Reduced 3.72%	61,042 $14.1 Million
Q2 2021 Aug 10, 2021	BUY	$180.55 - $233.54 $2.11 Million - $2.73 Million	11,698 Added 22.63%	63,398 $14.6 Million
Q1 2021 Aug 10, 2021	BUY	$164.32 - $212.72 $808,454 - $1.05 Million	4,920 Added 10.52%	51,700 $9.66 Million
Q1 2021 May 11, 2021	SELL	$164.32 - $212.72 $24,155 - $31,269	-147 Reduced 0.31%	46,780 $8.74 Million
Q4 2020 Feb 12, 2021	BUY	$130.46 - $172.63 $583,808 - $772,519	4,475 Added 10.54%	46,927 $7.92 Million
Q3 2020 Dec 10, 2020	BUY	$146.22 - $169.13 $555,343 - $642,355	3,798 Added 9.83%	42,452 $6.28 Million
Q2 2020 Aug 10, 2020	BUY	$136.42 - $164.18 $235,597 - $283,538	1,727 Added 4.68%	38,654 $6.35 Million
Q1 2020 May 18, 2020	BUY	$119.05 - $147.35 $1.07 Million - $1.33 Million	9,001 Added 32.23%	36,927 $5.12 Million
Q4 2019 Feb 13, 2020	BUY	$106.92 - $132.43 $21,277 - $26,353	199 Added 0.72%	27,926 $3.67 Million
Q3 2019 Nov 12, 2019	BUY	$106.79 - $116.16 $51,045 - $55,524	478 Added 1.75%	27,727 $3.1 Million
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $1.09 Million - $1.27 Million	-9,821 Reduced 26.49%	27,249 $3.02 Million
Q1 2019 Apr 23, 2019	BUY	$111.31 - $131.02 $374,669 - $441,013	3,366 Added 9.99%	37,070 $4.81 Million
Q1 2019 Apr 12, 2019	BUY	$111.31 - $131.02 $3.75 Million - $4.42 Million	33,704 New	33,704 $3.9 Million

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $716B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Mercer Global Advisors Inc with notifications on news.

Account

Mercer Global Advisors Inc Eli Lilly & CO Transaction History